NeuroRx Signs Agreement With U.S. Dept. of Veterans Affairs and Baylor College of Medicine for Clinical Trial of First Drug Regimen Targeting Severe Bipolar Depression in Patients With Acute Suicidal Ideation and Behavior (ASIB)

Third clinical research site for NRX-100 / NRX-101 phase 2B/3 clinical study WILMINGTON, Del., Dec. 27, 2017 -- (Healthcare Sales & Marketing Network) -- NeuroRx, a clinical stage biopharma company developing the first drug regimen to treat severe bipo... Biopharmaceuticals, Neurology NeuroRx, bipolar depression, ASIB
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news